Infectious Disease Point-of-care Diagnostics Industry: Rapid Testing Innovations
As per Fortune Business Insights’ report, the infectious disease point-of-care diagnostics Industry share sector attained a worth of USD 15.81 Billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of -2.8% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of USD 12.46 Billion by 2030, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the Industry in 2022.
Request a Free Sample PDF Brochure of Infectious Disease Point-of-care Diagnostics Industry: fortunebusinessinsights.com/enquiry/request..
In a recent study, Fortune Business Insights presents the nitty-gritty of the global Infectious Disease Point-of-care Diagnostics Industry considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and trends affecting Industry growth. Further, all the Industry shares associated with the Industry as well as the segments are expressed in terms of value and volume.
Top Companies in the Infectious Disease Point-of-care Diagnostics Industry:
F. Hoffmann-La Roche Ltd(Basel, Switzerland)
Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
Abbott Laboratories (Illinois, U.S)
Quest Diagnostics Incorporated (New Jersey, United States)
BD (Franklin Lakes, U.S)
bioMrieux SA (Marcy l'Etoile, France)
Cardinal Health, Inc.(Ohio, U.S)
Mesa Biotech (California, U.S)
Cepheid (California, U.S)
Trinity Biotech (Bray, Ireland)
Quidel Corporation (San Diego, U.S.)
Bio-Rad Laboratories Inc. (California, U.S)
Other Players
The Infectious Disease Point-of-care Diagnostics Industry study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each Industry player, including SWOT analysis, main Industry information, Industry share, revenue, pricing, and gross margin.
Infectious Disease Point-of-care Diagnostics Industry Dynamics:
Increasing prevalence of infectious diseases
Rising demand for rapid and accurate diagnostic tests
Advancements in technology and product innovation
Growing awareness and adoption of point-of-care diagnostics
Government initiatives and funding for healthcare infrastructure
Speak to Analyst for Queries: fortunebusinessinsights.com/enquiry/speak-t..
The insights for each vendor consist of:
Company profile
SWOT analysis
Main Industry information
Industry share
Revenue, pricing, and gross margin
Crucial insights in the Infectious Disease Point-of-care Diagnostics Industry research:
Underlying macro- and microeconomic factors impacting the growth of the Infectious Disease Point-of-care Diagnostics Industry.
Basic overview of Infectious Disease Point-of-care Diagnostics Industry, including Industry definition, classification, and applications.
Scrutinization of each Infectious Disease Point-of-care Diagnostics Industry player based on mergers & acquisitions, R&D projects, and product launches.
Adoption trend of Infectious Disease Point-of-care Diagnostics Industry across various industries.
Important regions and countries offer lucrative opportunities to Infectious Disease Point-of-care Diagnostics Industry stakeholders.
Important regions covered in the Infectious Disease Point-of-care Diagnostics Industry report include:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Table of Contents:
Introduction
Research Scope
Customer Segmentation
Data Gathering Strategies
Key Definitions & Caveats
Executive Summary
Industry Dynamics
Infectious Disease Point-of-care Diagnostics Industry Drivers
Infectious Disease Point-of-care Diagnostics Industry Restraints
Industry Opportunities
Key Insights
Value Chain
Major M&A moves and game-changing partnerships.
Covid-19 Impact
Future of the Healthcare Industry
Competitive Landscape
Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
Infectious Disease Point-of-care Diagnostics Industry Growth Size 2024
Strategies Adopted by Leading Players
Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
Disclaimer
TOC Continued…!
Order a copy of this research report at: fortunebusinessinsights.com/checkout-page/1..
FAQ’s
How big is the Infectious Disease Point-of-care Diagnostics Industry?
What factors are influencing the Infectious Disease Point-of-care Diagnostics Industry growth in North America?
Who are the key Infectious Disease Point-of-care Diagnostics Industry players?
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic Industry intelligence, giving a granular overview of the Industry they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive Industry studies interspersed with relevant data.
At Fortune Business Insights, we aim to highlight our clients' most lucrative growth opportunities. We, therefore, offer recommendations, making it easier for them to navigate through technological and Industry-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA:+1 424 253 0390,
United Kingdom: +44 2071 939123,
APAC: +91 744 740 1245